Confusion and chaos will reign this week as dozens of drug companies — including Pfizer (PFE) — scramble to figure out which of their drug studies were conducted by Cetero Research, after the FDA said on July 26 that employees there “were manipulating and falsifying data” in clinical trials between 2005 and 2010. Some of those tests may have to be redone — setting companies back years in their new drug launches and costing them millions of dollars in testing fees. Dozens of drug companies have done testing work through Cetero. There are currently 122 drug studies in progress in which Cetero has some role.
